Tonix Pharmaceuticals Now Plans To Submit IND For Long Covid Treatment TNX-102 SL In Q4

Tonix Pharmaceuticals Holding Corp. (TNXP) on Tuesday said it received official minutes from the pre-IND meeting with FDA to develop TNX-102 SL as a potential treatment for Long COVID Syndrome.

Based on the minutes, the company plans to submit the investigational new drug application in the fourth quarter of 2021 for a Phase 2 study of TNX-102 SL in a subset of Long COVID patients whose symptoms overlap with fibromyalgia.

TNX-102 SL, a patented sublingual tablet formulation of cyclobenzaprine hydrochloride is in mid-Phase 3 development for the treatment of fibromyalgia.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT